by Lyla El-Fayomi | Jul 17, 2025
The volume of clinical updates I encounter every month is steadily but very noticeably growing month over month! There are lots to get through, so in this rapid-fire edition of RMNU🔬, you’ll find short summaries on all the biggest headlines of the summer’s first half....
by Peace Chukwu | Jun 18, 2025
For decades, exosomes were seen as the cell’s garbage collection system. The understanding of their function was limited to cellular waste disposal, removing unwanted substances from the cell. Now, researchers are making the shift from using whole stem cells to...
by Krystal Jacques | May 29, 2025
Imagine a one-and-done treatment for stroke using the regenerative capacity of your brain. Tianhao Chen, Dr. Cindi Morshead’s lab, and Dr. Hani E. Naguib’s lab have developed a biodegradable electrode that can electrically stimulate neural precursor cells (NPCs). This...
by Lyla El-Fayomi | May 16, 2025
In this edition of RMNU🔬, we’re keeping up with multiple research advances in the vision repair field. Also, Vertex Pharmaceuticals is dropping a big therapeutic from their portfolio, and Longeveron has a new publication. Of course, yet another round of updates on...
by Medicine by Design | May 2, 2025
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This portrait is one in a series of portraits that feature “people of Medicine by Design.” Some minor...
by Lyla El-Fayomi | Apr 16, 2025
A brief recap You might recall Johanne Provost’s story, which I covered in the September edition of RMNU🔬. New details have since emerged regarding the specifics of her disease: Ms. Provost had been suffering from a rare autoimmune disease – lichen planus – that...
Comments